IP Library Granted Patent US 10,961,575
Granted Patent B2
US 10,961,575 · App. 16/570,093 · Granted Mar 30, 2021

Nanowire-based system for analysis of nucleic acids

Inventors: Hongye Sun (Belmont, CA); Steven Fung (Palo Alto, CA); Sam Lee Woo (Redwood City, CA)
Assignee: APPLIED BIOSYSTEMS, LLC
C12Q1/6874C12Q1/6811C12Q1/6869G01N27/3276G01N27/3278Y10T436/14Y10T436/142222Y10T436/143333
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,961,575
App. No.
16/570,093
Granted
Mar 30, 2021
Kind
B2
Abstract

A method for sequencing a nucleic acid template includes forming a nanowire assembly including a semiconductor nanowire and a probe covalently bound to the semiconductor nanowire; contacting the nanowire assembly with a template nucleic acid; contacting the nucleic acid duplexes with an extension nucleic acid, the extension nucleic acid joined to the probe; disrupting the nucleic acid duplexes; and measuring an electrical characteristic of a nanowire assembly of the set of nanowire assemblies.

Claims (25)

1. A method for sequencing a nucleic acid template, the method comprising:

forming a set of nanowire assemblies each including a semiconductor nanowire and a first nucleic acid covalently bound to the semiconductor nanowire at two or more sites along the nucleic acid, the semiconductor nanowire connected at a first end to a first electrode and at a second end to a second electrode, a detector connected to the electrodes to detect an electrical characteristic of the semiconductor nanowire;

contacting the set of nanowire assemblies with a second nucleic acid, the second nucleic acid forming a nucleic acid duplex with the first nucleic acid; and

measuring an electrical characteristic of a nanowire assembly.

2. The method of claim 1 , wherein the first nucleic acid is connected to a first binding member and the semiconductor nanowire is connected to a second binding member that specifically binds to the first binding member.

3. The method of claim 2 , wherein the first binding member or the second binding member is streptavidin and the second binding member or the first binding member is biotin.

4. The method of claim 2 , wherein the first nucleic acid is connected to two of the first binding members at sites spaced along the first nucleic acid.

5. The method of claim 4 , wherein the first binding members are spaced at opposite ends of the first nucleic acid.

6. The method of claim 1 , wherein the second nucleic acid is a primer, the method further comprising:

contacting the nanowire assemblies with a polynucleotide; and

contacting the nanowire assembly with a type of nucleotide for each of four different types of nucleotides corresponding to the nucleotides guanosine, adenosine, thymidine, and cytidine.

7. The method of claim 1 , further comprising, prior to measuring an electrical characteristic, disrupting the nucleic acid duplexes to render less stable nucleic acid duplexes single stranded.

8. The method of claim 7 , wherein disrupting includes changing a temperature of the set of nanowire assemblies.

9. The method of claim 7 , wherein disrupting includes adjusting an ionic strength of a solution surrounding the set of nanowire assemblies.

10. The method of claim 7 , wherein disrupting includes changing the concentration of an organic solvent.

11. The method of claim 7 , wherein disrupting includes enzymatically disrupting.

12. The method of claim 7 , wherein disrupting includes changing an electric field of a nucleic acid assembly.

13. The method of claim 1 , further comprising contacting the nucleic acid duplexes with an extension nucleic acid, the extension nucleic acid joining to the first nucleic acid.

14. The method of claim 13 , further comprising contacting the nanowire assembly with a ligase enzyme while contacting the extension nucleic acid.

15. The method of claim 13 , wherein the step of measuring includes a step of measuring substantially no change in the electrical characteristic of a select nanowire assembly, thereby indicating that the extension nucleic acid is not added to an associated probe.

16. The method of claim 13 , wherein the step of measuring determines a change in the electrical characteristic correlating the joining of the extension nucleic acid to the probe.

17. The method of claim 1 , wherein the second nucleic acid is a probe of a set of different probes that include a regions of nucleotide sequence variation in a population.

18. The method of claim 17 , wherein a variation in the region is disposed at or near an end of the probe.

19. The method of claim 17 , wherein the nucleotide sequence variation corresponds to a polymorphism in a population.

20. The method of claim 1 , further comprising forming a second nanowire assembly including a second semiconductor nanowire and a third nucleic acid covalently bound to the second semiconductor nanowire at two or more sites along the nucleic acid, wherein the nucleic acid assembly includes the first nucleic acid having a first region with a first nucleotide sequence variation and the second nucleic acid assembly includes the third nucleic acid having the region with a second nucleotide sequence variation.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2020
From: SUN, HONGYE; FUNG, STEVEN; WOO, SAM LEE
To: APPLERA CORPORATION
Reel/Frame 051629/0470 →
MERGER Recorded Jan 27, 2020
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 051629/0504 →
MERGER Recorded Jan 27, 2020
From: ATOM ACQUISITION CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 051629/0570 →
MERGER Recorded Jan 27, 2020
From: APPLIED BIOSYSTEMS INC. & ATOM ACQUSITION, LLC
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 051629/0644 →